Since 2001 PAL Technologies has been providing support from its headquarters in Glasgow to more than 200 institutions worldwide. Many of the researchers and clinicians utilising PAL’s devices are investigating the correlation between physical behaviours and chronic disease to help inform treatment interventions and chronic disease risk.
The core technology behind the PAL family of products has been developed and refined over a number of years using both patient groups and unimpaired subjects. Researchers and clinicians found that although they could easily measure the walking skills and exercise tolerance of their patients and subjects in the laboratory, this told them little about the type and level of activities they actually did when they were at home or work. As self-report diaries can be less than reliable, PAL undertook to develop simple and unobtrusive technologies to accurately describe posture allocation and free-living activity in order to provide the researchers, clinicians and anyone else with an interest in quantifying sedentary, upright and ambulatory activities with the detailed evidence they required.
PAL Technologies was spun out from the Bioengineering Unit of the University of Strathclyde in 2001. The Unit has an exceptional reputation for cross-disciplinary research and innovation. Today PAL continues to be run by three of the original co-founders – Douglas Maxwell, Dr Nikos Mourselas and Professor Malcolm Granat who bring a range of complementary skills to the company.
chief executive officer
As Chief Executive Officer, Dougie brings a wealth of experience and expertise to PAL including a first degree in physiology and solid clinical experience gained in bioengineering research. With experience in delivering clinical rehabilitation programmes, functional electrical stimulation (FES), health telematics, movement analysis and free-living ambulatory monitoring across a range of subject groups. A skilled multimedia programmer and developer, he is also well versed in innovation and entrepreneurship as a graduate of both the Strathclyde Entrepreneurship Initiative and the USCD Summer School in Innovation and Entrepreneurship in San Diego. Winning a Royal Society of Edinburgh Enterprise Fellowship however, was the catalyst which allowed him to pull together the business case articulating the commercial potential of PAL’s products.
Dr Nikos Mourselas
Technical Director Nikos Mourselas has a first degree in engineering, an MSc in Control Systems and a PhD in Bioengineering. A Greek national, Nikos also co-founded C&I Technics Ltd, a technology company based in Athens which specialised in industrial automation products, and Biomedical Monitoring Ltd which designs and develops microprocessor based products for the medical and bioengineering fields. Nikos’ research work has included the development of clinical functional electrical stimulation (FES) systems and ambulatory cardiac monitoring.
Prof Malcolm Granat
Malcolm Granat combines his role as a Professor and respected research-active academic at Salford University with the role of part-time Clinical Director of PAL Technologies. Malcolm has a BSc in Medical Biochemistry and a PhD in Bioengineering and his research interests can be broadly classified into three areas. The first is the development of functional electrical stimulation (FES) based systems for the restoration of movement in neurological conditions including spinal cord injury, stroke and cerebral palsy, the second is the clinical evaluation of novel therapies principally, although not exclusively, relating to mobility and ambulation and the third is the development of novel instrumentation and outcome measures in support of the broad aims of the first two areas. Currently he is engaged in a number of programmes looking at quantification of free-living activity in a range of populations and conditions and is also exploring the use of activity monitoring as an aid to decision making for healthcare professionals.